NLRP3 and stroke disorder: To investigate whether ISO offers retinal protection against stroke-induced retinal injury in diabetes, we administered ISO prior to middle cerebral artery occlusion (MCAO) in diabetic mice and studied the role of NLRP3 inflammasome activation in the retina.